A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

Objective. Iron isomaltoside 1000 (Monofer®) is a high-dose intravenous (IV) iron, which in a recent 8 weeks trial in inflammatory bowel disease (IBD) subjects with iron deficiency anemia (IDA) demonstrated good tolerability and efficacy. The present trial is an extension to this trial, which evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinisch, Walter, Altorjay, Istvan, Zsigmond, Ferenc, Primas, Christian, Vogelsang, Harald, Novacek, Gottfried, Reinisch, Sieglinde, Thomsen, Lars L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673551/
https://www.ncbi.nlm.nih.gov/pubmed/25900645
http://dx.doi.org/10.3109/00365521.2015.1031168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673551/
https://www.ncbi.nlm.nih.gov/pubmed/25900645
http://dx.doi.org/10.3109/00365521.2015.1031168

Ejemplares similares